Volume 7: Medicines and Cosmetics
Index

M

MacGregor, Mr John  2,  3,  4,  5,  6,  7,  8

Maclean, Mr  2

MacOwan, Dr  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12,  13,  14

MAFF see Ministry of Agriculture, Fisheries and Food

MAIL see Medicines Act Information Leaflet

management context of review exercise

Manufacturers Registration Scheme (MRS)  2,  3,  4

manufacturing chemists, as excepted premises  2,  3,  4

Marketing Authorisations for Veterinary Medicinal Products Regulations 1994

Martin, Dr  2,  3,  4,  5

Maslin, Mr  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12,  13

Matthews, Dr  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12

MBM see meat and bone meal

MCA see Medicines Control Agency

McIvor, Mr

MDA see Medical Devices Agency

MDD see Medical Devices Directorate

measles vaccine  2,  3,  4,  5,  6,  7

Meat (Staining and Sterilisation) Regulations 1982  2,  3

meat and bone meal (MBM)  2,  3,  4,  5

Meat Hygiene Division, MAFF  2

Meat Trade Adviser

Medical Assessor, DH  2,  3

medical devices  2,  3,  4,  5

Medical Devices Agency (MDA)  2,  3,  4

Medical Devices Directive 93/42/EEC

Medical Devices Directorate (MDD)  2,  3,  4,  5,  6

Medical Devices Regulations 1994

medical devices, BSEWG's view

medical devices, compliance of manufacturers with guidelines

medical devices, consideration by BSE Working Group

medical devices, follow-up of guidelines

medical devices, guidelines  2

medical devices, implications of human SBO ban

medical devices, non-responses

medical devices, questionnaire  2

medical devices, regulation of  2

medical devices, response on  2

medical devices, response to questionnaire  2

medical devices, responsibility for

medical devices, safety of

medical devices, sterilisation

Medical Division, Divisional Management Group

Medical Research Council (MRC)  2

Medical Research Council (MRC), funding of BSE research

Medical Toxicology Environmental Protection (MEDTEP)  2,  3

medicinal products  2,  3

medicinal products, safety of

medicinal purposes

Medicines (Applications for Grant of Product Licences - Products for Human Use) Regulations 1993

Medicines (Applications for Product Licences and Clinical Trial and Animal Test Certificates) Regulations 1971  2

Medicines (Committee on the Review of Medicines) Order 1975

Medicines (Exemption from Licences) (Foods and Cosmetics) Order 1971

Medicines (First Appointed Day) Order 1971

Medicines (Homoeopathic Medicinal Products for Human Use) Regulations 1994

Medicines Act 1968  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12,  13,  14,  15,  16,  17,  18,  19,  20,  21,  22,  23,  24,  25,  26,  27,  28,  29

Medicines Act 1968, exemptions from

Medicines Act 1968, provisions regarding non-disclosure

Medicines Act 1971

Medicines Act Information Leaflet (MAIL)  2,  3,  4,  5

Medicines Act Leaflet (MAL 67)

Medicines Commission  2,  3,  4

Medicines Control Agency (MCA)  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12,  13,  14,  15,  16,  17,  18

Medicines Control Agency (MCA) see also Medicines Division

Medicines Control Agency (MCA), audit of manufacturers

Medicines Control Agency (MCA), BSE database out of date

Medicines Control Agency (MCA), Business Groups  2

Medicines Control Agency (MCA), changing Directorship of

Medicines Control Agency (MCA), consideration of research required

Medicines Control Agency (MCA), Director

Medicines Control Agency (MCA), impact on handling

Medicines Control Agency (MCA), issues arising from BSEWG meeting

Medicines Control Agency (MCA), liaison with MAFF

Medicines Control Agency (MCA), perception of remote risk to humans

Medicines Control Agency (MCA), progress report to VMD

Medicines Control Agency (MCA), responsibility for follow-up of guidelines

Medicines Control Agency (MCA), views on catgut

Medicines Directorate  2

Medicines Division  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12,  13,  14,  15,  16,  17,  18,  19,  20,  21,  22,  23,  24,  25,  26,  27,  28,  29,  30

Medicines Division see also Medicines Control Agency

Medicines Division, administrative staff

Medicines Division, advice from section 4 committees

Medicines Division, chain of responsibility within

Medicines Division, communication with MAFF  2

Medicines Division, computing and information technology

Medicines Division, consideration of BSE in

Medicines Division, consideration of BSE problem by section 4 committees

Medicines Division, covering letter sent by

Medicines Division, Divisional Management Group

Medicines Division, early knowledge of BSE

Medicines Division, end of involvement in BSE

Medicines Division, expert advice obtained by

Medicines Division, inadequacy of response  2

Medicines Division, learns about BSE

Medicines Division, limitations of database  2

Medicines Division, MB1 unit

Medicines Division, MB3A unit

Medicines Division, MB3B unit

Medicines Division, MB4 unit

Medicines Division, MB5 unit

Medicines Division, medical staff

Medicines Division, overload and delay

Medicines Division, paper files

Medicines Division, pharmaceutical staff

Medicines Division, problems within

Medicines Division, request for information in MAIL

Medicines Division, response to BSE concern  2

Medicines Division, response to CMO's concerns  2,  3

Medicines Division, responsibility for follow-up of guidelines

Medicines Division, staffing levels

Medicines Division, structural/organisational difficulties

Medicines for Human Use (Marketing Authorisations Etc.) Regulations 1994  2

Medicines Unit  2,  3,  4,  5,  6

medicines, animal see veterinary medicines

medicines, human see human medicines

medicines, licensing  2

MEDTEP see Medical Toxicology Environment Protection

Meldrum, Mr  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12,  13,  14,  15,  16,  17,  18,  19

Mellor, Mr David

Merck Sharp & Dohme

Merieux

Metters, Dr  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12,  13

milk  2,  3,  4,  5,  6,  7

milk derivatives

milk products  2

milk products, bovine

milk-fed cows

Minister for Agriculture  2,  3,  4,  5,  6

Ministerial involvement in decisions regarding existing stocks

Ministers, decision-making role of

Ministers, Department of Health

Ministers, reporting to

Ministry of Agriculture, Fisheries and Food (MAFF)  2,  3,  4,  5,  6

Ministry of Agriculture, Fisheries and Food (MAFF), briefing to Ministers

Ministry of Agriculture, Fisheries and Food (MAFF), Chief Scientists Group

Ministry of Agriculture, Fisheries and Food (MAFF), chronological account of BSE

Ministry of Agriculture, Fisheries and Food (MAFF), communication with Medicines Division  2

Ministry of Agriculture, Fisheries and Food (MAFF), consideration of fate of cattle tissues

Ministry of Agriculture, Fisheries and Food (MAFF), covering letter sent by

Ministry of Agriculture, Fisheries and Food (MAFF), detailed proposals for intended SBO ban

Ministry of Agriculture, Fisheries and Food (MAFF), initial response

Ministry of Agriculture, Fisheries and Food (MAFF), issue of joint CSM/VPC guidelines  2

Ministry of Agriculture, Fisheries and Food (MAFF), lack of communication with DH  2

Ministry of Agriculture, Fisheries and Food (MAFF), liaison with MCA

Ministry of Agriculture, Fisheries and Food (MAFF), Meat Hygiene Division  2

MInistry of Agriculture, Fisheries and Food (MAFF), meeting with NOAH

Ministry of Agriculture, Fisheries and Food (MAFF), new audit proposals

Ministry of Agriculture, Fisheries and Food (MAFF), opinion on cosmetics

Ministry of Agriculture, Fisheries and Food (MAFF), perceptions of

Ministry of Agriculture, Fisheries and Food (MAFF), Permanent Secretary  2

Ministry of Agriculture, Fisheries and Food (MAFF), response to audit proposals

Ministry of Agriculture, Fisheries and Food (MAFF), responsibilities for veterinary medicines licensing

Ministry of Agriculture, Fisheries and Food (MAFF), responsibility for safety of human and veterinary medication

Ministry of Agriculture, Fisheries and Food (MAFF), Scientific Secretariat

mink

Minor, Dr  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12,  13,  14,  15,  16

Minor, Dr, concerns about gelatin

MMR vaccine  2,  3,  4,  5,  6

monoclonal antibodies  2,  3

mouse

MRC see Medical Research Council

MRS see Manufacturers Registration Scheme

Mulholland, Miss  2,  3

mumps vaccine  2

Murray, Mr Tom  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12,  13,  14,  15,  16,  17,  18

muscle

mycological media

N

named patient supplies  2,  3

nasal septum

National Health Service (NHS)

National Health Service (NHS), in-house manufactured products

National Institute for Biological Standards and Control (NIBSC)  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12,  13,  14,  15,  16,  17,  18,  19

National Institute for Biological Standards and Control (NIBSC), meeting convened at  2,  3,  4

National Institute for Biological Standards and Control (NIBSC), responsibility for advice on safety of biological products

National Institute for Biological Standards and Control (NIBSC), Viral Products Advisory Panel

National Office of Animal Health (NOAH)  2,  3,  4,  5,  6,  7

National Office of Animal Health (NOAH), concerns regarding guidelines

National Office of Animal Health (NOAH), Liaison Group

National Office of Animal Health (NOAH), meeting with MAFF

NCS see new-born calf serum

needles, disposable  2,  3,  4

needlestick injuries

neural tissue  2,  3,  4,  5,  6,  7

Neuropathogenesis Unit (NPU)  2,  3,  4,  5,  6,  7,  8,  9,  10

Neuropathogenesis Unit (NPU), infectivity studies at

New Active Substances

New Drugs and European Licensing unit

New Drugs Group

New Zealand  2

New Zealand, as safe source of BSE-free herds  2

New Zealand, as source of catgut

new-born calf serum (NCS)  2

Next Steps Agency

NHS see National Health Service

NHS Supplies Authority

NIBSC see National Institute for Biological Standards and Control

NOAH see National Office of Animal Health

non-complying products  2

Norsk product licence database  2,  3,  4

Northern Ireland  2,  3,  4

notice to warn

Notified Bodies

NPU see Neuropathogenesis Unit

O

O'Brien, Mr J

occupational risks

oesophagus  2

offal  2

ointments

Oman  2

omasum  2

omnivores, introduction of BSE into

ophthalmic products

oral medicinal products  2,  3,  4,  5,  6,  7,  8,  9,  10,  11

oral medicinal products, exemption from guidelines

orthopaedic implants

Otley, Mr

ova

ox heart in diphtheria vaccine

ox liver  2,  3

Oxoid  2

P

pacemakers  2,  3

pancreas  2,  3,  4,  5,  6

paper files

parenteral medicinal products  2,  3,  4,  5,  6,  7,  8

Parliamentary Answer  2,  3,  4

Parliamentary Question  2

Parliamentary Secretary

Parliamentary Under-Secretary  2,  3

Pattison, Professor

Payne, Mrs  2,  3,  4,  5,  6,  7,  8,  9,  10

PD see Procurement Directorate

peptone  2,  3,  4,  5,  6

peptone meat broths

Perfumery Working Group  2

Permanent Secretary  2

pertussis vaccine

PES see Public Expenditure Survey

pharmaceutical industry  2,  3,  4,  5,  6,  7,  8

pharmaceutical industry, exemption from SBO ban  2,  3,  4

pharmaceutical industry, guidance for

pharmaceutical industry, guidelines for

pharmaceutical industry, precautionary measures taken

pharmaceutical industry, use of bovine products by

Pharmaceutical Supply and Technology Section (PSTS)

pharmaceuticals  2

Pharmaceuticals team, VMD

pharmaceuticals, exemption from Medical Act

pharmaceuticals, Tyrrell Report

Pharmacovigilance

Pharmacovigilance unit  2

Pharmacy Division

Phillipson, Mr Ian  2,  3,  4,  5

Pickles, Dr Hilary  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12,  13,  14,  15,  16,  17,  18,  19,  20,  21,  22,  23,  24,  25,  26,  27,  28,  29,  30,  31,  32,  33,  34,  35,  36,  37,  38,  39,  40,  41,  42,  43,  44,  45,  46,  47,  48,  49,  50,  51,  52,  53,  54,  55,  56

Pickles, Dr Hilary, briefing to Parliamentary Under-Secretary

Pickles, Dr Hilary, BSE in Switzerland

Pickles, Dr Hilary, correspondence

Pickles, Dr Hilary, minute to Miss Duncan

Pickles, Dr Hilary, paper for SEAC  2,  3

Pickles, Dr Hilary, paper for Southwood Working Party

Pickles, Dr Hilary, query on manufacturers using banned products

Pickles, Dr Hilary, query regarding contact lenses

Pickles, Dr Hilary, Question and Answer briefing

pig brain

pig, transmission of BSE to  2

pituitary gland  2,  3,  4,  5

pituitary gland, extraction of hormones from

pituitary hormones

placenta  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12,  13,  14,  15,  16,  17,  18

placenta, ovine  2

placenta, transmission of scrapie via

PLR see Product Licence of Right

PLUS see Product Licence User System

PMO see Principal Medical Officer

policy framework for action

polio vaccine  2

porcine insulin  2

porcine material

Porton Products

Portugal

Post-Licensing Division, MCA  2

Pratt, Mr

pressure, avoidance in decision making

Principal Medical Assessor

Principal Medical Officer (PMO)  2,  3,  4

Principal Pharmaceutical Officer  2,  3

prion

Proctor & Gamble

Procurement Directorate (PD)  2,  3,  4,  5,  6,  7,  8,  9

Procurement Directorate (PD), records of meetings

Procurement Directorate (PD), responsibility for devices not covered by Medicines Act

Procurement Directorate (PD), responsibility for follow-up of guidelines

Procurement Directorate (PD), restructuring of

Product Licence of Right (PLR)  2,  3,  4,  5,  6,  7,  8,  9

Product Licence User System (PLUS) database  2,  3

Product Licence Variation  2

product licences  2,  3,  4,  5

product licences, existing

product licences, informal action

product licences, new  2

product licences, renewal

product licences, responsibility for granting

product licences, revocation  2

product licences, suspension

prohibition notice  2

proposals C2a and C2b  2,  3

proposals C2a and C2b, allocation of responsibility for

proposals C2a and C2b, funding of

proposals C2a and C2b, priority of

PSTS see Pharmaceutical Supply and Technology Section

Public Expenditure Survey (PES)

Purves, Dr John  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12,  13,  14,  15,  16,  17,  18,  19,  20,  21,  22,  23,  24,  25,  26,  27,  28,  29,  30,  31,  32,  33,  34,  35,  36,  37,  38,  39,  40

Purves, Dr John, BSE paper  2,  3,  4,  5

Q

Question and Answer briefing  2

questionnaire  2,  3

questionnaire, administrative difficulties in reviewing data  2

questionnaire, conclusions on effectiveness of

questionnaire, deadline for response

questionnaire, on cosmetics  2

questionnaire, on medical devices  2

questionnaire, responses to  2,  3,  4

R

rabies vaccine  2

Raine, Dr June  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12,  13

Rawlins, Professor MD

reagent

recombinant DNA technologies  2

recombinant human insulin  2,  3

recombinant vaccines

recruitment of professional staff

red meat

Redborne, Mrs Deborah

Rees, Mr  2

relative infectivity of tissues

Render, Dr

renderers

rendering

rennet

rennet manufacture

reproductive organs

Republic of Ireland  2,  3,  4,  5,  6

Republic of Ireland, application of guidelines to

Research Management Division  2,  3

retention of professional staff

reticulum  2

Rhodes, Mr

Richardson, Dr  2

Ridley, Dr R  2,  3

ring-fencing of medicines licensing

risk assessment  2,  3,  4

risk material, management of

risk products

risk/benefit analysis

risk/benefit ratio  2,  3,  4,  5

Rogers, Dr Alan

Rogers, Mr Chris  2,  3,  4,  5

Roscoe, Mr  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12,  13

rotavirus vaccine

Rotblat, Dr Frances  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12,  13,  14,  15,  16,  17,  18,  19,  20,  21,  22,  23,  24,  25,  26

Rotblat, Dr Frances, BSE paper  2,  3,  4,  5

Rotblat, Dr Frances, paper on vaccines  2

Royal Environmental Health Institute of Scotland

Royal Environmental Health Institute of Scotland, comment on SBO ban

Royal Society of Medicine

Royal Society of Medicine, presentation on veterinary medicines to

Royal Veterinary College (RVC)

rubella vaccine  2,  3

Rubery, Dr Eileen

rumen  2

ruminant-derived protein  2,  3,  4,  5,  6,  7

ruminants

Rutter, Dr J M  2,  3,  4,  5,  6,  7,  8